Description
Product details :
Revitalift Laser Tri-Peptide Age-Correcting Serum, 30ml. Advanced 3-in-1 Triple Action Formula with Hyaluronic Acid and Vitamin C for Radical Wrinkle Reduction and Firmness
Target the primary signs of aging with the L’Oréal Paris Revita lift Laser Tri-Peptide Serum. This high-performance formula combines three powerful dermatological serums into one daily treatment to address wrinkles, loss of firmness, and uneven skin texture. Powered by a specialized Tri-Peptide complex, it supports the skin’s natural renewal process, leaving the complexion looking smoother, firmer, and more youthful. The lightweight, fast-absorbing texture layers perfectly under moisturizer and makeup for all-day comfort.
Why You will Love It:
This breakthrough serum offers a professional-grade approach to anti-aging by delivering the benefits of three serums in a single drop. You will love how it immediately boosts hydration and radiance, while the clinical-grade ingredients work overtime to significantly reduce the appearance of deep expression lines and restore bounciness to your complexion.
How to Apply:
- Cleanse: Begin by cleansing your face to prepare the skin for the treatment.
- Tone: Apply toner (optional) to refresh and smooth the skin surface.
- Apply: Dispense a few drops of the Laser Tri-Peptide Serum onto the face and neck, avoiding the eye area.
- Moisturize: Follow with your Revita lift Laser day or night cream to lock in the benefits.
- Protect: During the morning routine, always finish with an SPF for daily skin protection.
Key Benefits:
- Tri-Peptide Power: Helps smooth expression lines while boosting collagen production for enhanced skin firmness.
- Hyaluronic Acid Hydration: Deeply hydrates and replums the skin surface to reduce the look of dehydration lines.
- Vitamin C Radiance: Intensifies skin luminosity and promotes a more even skin tone.
- Fast Transformation: Visible results in as little as two weeks with improved smoothness and refined texture.















Reviews
There are no reviews yet.